beta-Funaltrexamine
beta-Funaltrexamine (β-funaltrexamine) is an antagonist at μ-opioid receptors used experimentally.[1] Chemically, it is an amide of methyl fumarate with a naltrexone derivative.
Names | |
---|---|
IUPAC name
Methyl (2E)-4-{[(5α,6β)-17-(cyclopropylmethyl)-3,14-dihydroxy-4,5-epoxymorphinan-6-yl]amino}-4-oxo-2-butenoate | |
Identifiers | |
3D model (JSmol) |
|
Abbreviations | β-FNA |
ChEBI | |
ChEMBL | |
ChemSpider | |
KEGG | |
PubChem CID |
|
| |
| |
Properties | |
C25H30N2O6 | |
Molar mass | 454.523 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
See also
References
- Huang, Weijiao; Manglik, Aashish; Venkatakrishnan, A. J.; Laeremans, Toon; Feinberg, Evan N.; Sanborn, Adrian L.; Kato, Hideaki E.; Livingston, Kathryn E.; Thorsen, Thor S.; Kling, Ralf C.; Granier, Sébastien; Gmeiner, Peter; Husbands, Stephen M.; Traynor, John R.; Weis, William I.; Steyaert, Jan; Dror, Ron O.; Kobilka, Brian K. (2015). "Structural insights into µ-opioid receptor activation". Nature. 524 (7565): 315–321. doi:10.1038/nature14886. PMC 4639397. PMID 26245379.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.